[시장보고서]세계의 인간 재조합 DNA 시장

	세계의 인간 재조합 DNA 시장 Human Recombinant DNA: Global Markets
리서치사	BCC Research
발행일	2022년 07월	상품코드	1105254
페이지 정보	영문 84 Pages	배송안내
가격	US $ 5,500 ￦ 7,207,000 PDF & Excel (Single User License) US $ 6,600 ￦ 8,649,000 PDF & Excel (2-5 Users) US $ 7,920 ￦ 10,379,000 PDF & Excel (Site License) US $ 9,504 ￦ 12,454,000 PDF & Excel (Enterprise License)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 인간 재조합 DNA 시장 규모는 2022년까지 3,487억 달러에 달할 것으로 보입니다.

시장은 2022-2027년 예측기간 중 7.3%의 CAGR로 확대되고, 2027년에는 4,969억 달러를 넘어설 것으로 예측됩니다.

세계의 인간 재조합 DNA(Human Recombinant DNA) 시장에 대해 조사했으며, 시장 개요와 함께 제품 종류별, 최종사용자별, 지역별 동향, COVID-19의 영향 및 시장에 참여하는 기업 개요 등을 제공합니다.

List of Tables

Summary Table : Global Market for Human Recombinant DNA, by Region, Through 2027
Table 1 : Estimated World Population and Annual Growth, by Selected Age Group, Through 2030
Table 2 : Cancer Statistics Across Major Asian Countries, by Cancer Site/Type, 2020
Table 3 : Global Human Recombinant DNA Market, by Product Type, Through 2027
Table 4 : Global Market for Human Protein Replacements, by Region, Through 2027
Table 5 : Global Market for Therapeutic Agents for Human Diseases, by Region, Through 2027
Table 6 : Vaccine Types
Table 7 : Global Market for Vaccines, by Region, Through 2027
Table 8 : Global Market for Human Recombinant DNA, by End User, Through 2027
Table 9 : Global Market for Human Recombinant DNA in the Biotechnology and Pharmaceutical Industry, by Region, Through 2027
Table 10 : Global Market for Human Recombinant DNA in Research Laboratories and Academic Institutes, by Region, Through 2027
Table 11 : Global Market for Human Recombinant DNA, by Region, Through 2027
Table 12 : North American Market for Human Recombinant DNA, by Product Type Through 2027
Table 13 : North American Market for Human Recombinant DNA, by End User, Through 2027
Table 14 : North American Market for Human Recombinant DNA, by Country, Through 2027
Table 15 : European Market for Human Recombinant DNA, by Product Type, Through 2027
Table 16 : European Human Recombinant DNA Market, by End User, Through 2027
Table 17 : European Market for Human Recombinant DNA, by Country, Through 2027
Table 18 : Asia-Pacific Market for Human Recombinant DNA, by Product Type, Through 2027
Table 19 : Asia-Pacific Human Recombinant DNA Market, by End User, Through 2027
Table 20 : Asia-Pacific Market for Human Recombinant DNA, by Country, Through 2027
Table 21 : Japan: Total Number of New Cancer Cases in Both Genders, 2020
Table 22 : RoW Market for Human Recombinant DNA, by Product Type, Through 2027
Table 23 : RoW Market for Human Recombinant DNA, by End User, Through 2027
Table 24 : Leading Market Players in the Human Recombinant DNA Market Ecosystem
Table 25 : AbbVie Inc.: Business Segments
Table 26 : AbbVie Inc.: Financial Performance, Through 2020
Table 27 : Amgen: Financial Performance, Through 2020
Table 28 : Eli Lilly: Business Segments
Table 29 : Eli Lilly: Financial Performance, 2018-2020
Table 30 : Sanofi: Business Segments
Table 31 : Sanofi: Financial Performance, 2018-2020

List of Figures

Summary Figure A : Global Market for Human Recombinant DNA, by Region, 2020-2027
Summary Figure B : Global Market Shares of Human Recombinant DNA, by Region, 2021
Figure 1 : Global Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 2 : Global Market for Human Recombinant DNA, by Product Type, 2020-2027
Figure 3 : Global Market for Human Protein Replacements, 2020-2027
Figure 4 : Global Market for Therapeutic Agents for Human Diseases, 2020-2027
Figure 5 : Evolution of Vaccine Technologies
Figure 6 : Global Market for Vaccines, 2020-2027
Figure 7 : Global Market Shares of Human Recombinant DNA, by End User, 2021
Figure 8 : Global Market for Human Recombinant DNA, by End User, 2020-2027
Figure 9 : Global Market for Human Recombinant DNA in the Biotechnology and Pharmaceutical Industry, 2020-2027
Figure 10 : Global Market for Human Recombinant DNA in Research Laboratories and Academic Institutes, 2020-2027
Figure 11 : Global Market Shares of Human Recombinant DNA, by Region, 2021
Figure 12 : North American Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 13 : North American Market Shares of Human Recombinant DNA, by End User, 2021
Figure 14 : North American Market Shares of Human Recombinant DNA, by Country, 2021
Figure 15 : U.S. Market for Human Recombinant DNA, 2020-2027
Figure 16 : Canadian Market for Human Recombinant DNA, 2020-2027
Figure 17 : European Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 18 : European Human Recombinant DNA Market, Market Shares, by End User, 2021
Figure 19 : European Market Shares of Human Recombinant DNA, by Country, 2021
Figure 20 : Geriatric Population in Germany, 2000-2030
Figure 21 : German Market for Human Recombinant DNA, 2020-2027
Figure 22 : U.K. Market for Human Recombinant DNA, 2020-2027
Figure 23 : French Market for Human Recombinant DNA, 2020-2027
Figure 24 : Italian Market for Human Recombinant DNA, 2020-2027
Figure 25 : Spanish Market for Human Recombinant DNA, 2020-2027
Figure 26 : Rest of Europe Market for Human Recombinant DNA, 2020-2027
Figure 27 : Asia-Pacific Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 28 : Asia-Pacific Human Recombinant DNA Market, Market Shares, by End User, 2021
Figure 29 : Asia-Pacific Market Shares of Human Recombinant DNA, by Country, 2021
Figure 30 : New Cancer Cases in China, 2020
Figure 31 : Distribution of New Cancer Cases in China, 2020
Figure 32 : Chinese Market for Human Recombinant DNA, 2020-2027
Figure 33 : Japanese Market for Human Recombinant DNA, 2020-2027
Figure 34 : Indian Market for Human Recombinant DNA, 2020-2027
Figure 35 : Rest of Asia-Pacific Market for Human Recombinant DNA, 2020-2027
Figure 36 : New Cancer Cases in Africa, 2020
Figure 37 : RoW Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 38 : RoW Market Shares of Human Recombinant DNA, by End User, 2021
Figure 39 : AbbVie Inc.: Net Revenue, by Business Segment, 2020
Figure 40 : AbbVie Inc.: Net Revenue, by Region, 2020
Figure 41 : Amgen: Total Sales, by Product, 2020
Figure 42 : Amgen: Total Revenue, by Region, 2020
Figure 43 : Eli Lilly: Total Sales, by Product Segment, 2020
Figure 44 : Eli Lilly: Total Revenue, by Region, 2020
Figure 45 : Sanofi: Net Sales, by Business Segment, 2020
Figure 46 : Sanofi: Net Sales, by Region, 2020

Highlights:

The global human recombinant DNA market should reach $348.7 billion by 2022 and more than $496.9 billion by 2027, with a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2022-2027.

North American human recombinant DNA market should reach $150.8 billion by 2022 and more than $191.7 billion by 2027, with a CAGR of 4.9% during the forecast period of 2022-2027.

Asia-Pacific human recombinant DNA market should reach $86 billion by 2022 and more than $136.2 billion by 2027, with a CAGR of 9.6% during the forecast period of 2022-2027.

Report Scope:

This report highlights the current and future market potential for human recombinant DNA and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, trends and key players in the market. The report also provides market projections from 2022 through 2027. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, and market forces are also provided.

Report Includes:

24 data tables and 8 additional tables
An overview of the global market for human recombinant DNA
Estimation of the market size and analyses of global market trends, with data from 2020, 2021 with projections of compound annual growth rates (CAGRs) through 2026
Highlights of the market potential for human recombinant DNA, based on product, application, and region
Coverage of history and future of human recombinant DNA, and latest technological advancements of the industry
Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
Coverage of regulatory landscape, product recalls, pipeline products, and discussion on future perspective, strategies, and developments of the industry
Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
Company profiles of major players within the industry AbbVie Inc., Amgen Inc., Eli Lilly, Sanofi

Chapter 1 Introduction

Introduction
Study Goals and Objectives
Reasons for Doing the Study
Intended Audience
Scope and Format
Methodology
Market Estimates
Information Sources
Geographical Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview

Homologous Recombination (HR)
Targets for Cancer Therapy

Chapter 4 Impact of COVID-19 Pandemic

Chapter 5 Market Dynamics

Market Drivers
Increasing Incidences of Chronic Diseases
Growing Aging Population
Advancements in Manufacturing Technologies
Market Restraints
Price Controls
Entry of Biosimilars
Opportunities
Untapped Potential in Emerging Markets

Chapter 6 Market Breakdown by Product Type

Human Protein Replacements
Market Size and Forecast
Therapeutic Agents for Human Diseases
Market Size and Forecast
Vaccines
Types of Vaccines
Market Size and Forecast

Chapter 7 Market Breakdown by End User

Biotechnology and Pharmaceutical Industry
Market Size and Forecast
Research Laboratories and Academic Institutes
Market Size and Forecast

Chapter 8 Market Breakdown by Region

Global Market by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 9 Competitive Landscape

Overview

Chapter 10 Company Profiles

ABBVIE INC.
ALEXION PHARMACEUTICALS
AMGEN INC.
ELI LILLY
MERCK & CO. INC.
SANOFI S.A.
TAKEDA PHARMACEUTICAL CO LTD.

F A Q

세계의 인간 재조합 DNA 시장

Human Recombinant DNA: Global Markets

목차

제1장 서론

제2장 정리와 하이라이트

제3장 개요

제4장 COVID-19 팬데믹의 영향

제5장 시장 역학

제6장 시장 내역, 제품 종류별

제7장 시장 내역, 최종사용자별

제8장 시장 내역, 지역별

제9장 경쟁 상황

제10장 기업 개요